Skip Navigation

European Heart Journal 2004 25(12):1009-1013; doi:10.1016/j.ehj.2004.03.021
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Luca, G.
Right arrow Articles by Suryapranata, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Luca, G.
Right arrow Articles by Suryapranata, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical research

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty

Giuseppe De Luca*, Arnoud W.J van't Hof, Menko-Jan de Boer, Jan Paul Ottervanger, Jan C.A Hoorntje, A.T.Marcel Gosselink, Jan-Henk E Dambrink, Felix Zijlstra and Harry Suryapranata*

Department of Cardiology, ISALA Klinieken, Hospital De Weezenlanden, Groot Wezenland, 20, Zwolle 8011 JW, The Netherlands

* Corresponding authors. Tel.: +31-38-4244242; fax: +39-38-4243083
E-mail address: g.deluca{at}diagram-zwolle.nl

Received 12 November 2003; revised 18 March 2004; accepted 24 March 2004 See page 1001 for the editorial comment on this article1

Abstract

Aims The prognostic role of time-to-treatment in primary angioplasty is still a matter of debate. The aim of our study was to evaluate the relationship between time-to-treatment and myocardial perfusion in patients with ST-segment-elevation myocardial infarction (STEMI) treated by primary angioplasty.

Methods and results Our study population consisted of 1072 patients with STEMI treated by primary angioplasty from 1997 to 2001. Myocardial perfusion was evaluated by using ST-segment resolution and myocardial blush grade. Time-to-treatment was defined as the time from symptom-onset to the first balloon inflation. Time-to-treatment was significantly associated with the extent of ST-segment resolution, myocardial blush grade, enzymatic infarct size, and 1-year mortality. After adjustment for baseline confounding factors, time-to-treatment was still associated with impaired ST-segment resolution (adjusted OR [95% CI]=1.01 [1.01–1.02], ) and myocardial blush (adjusted OR [95% CI]=1.01 [1.01–1.02], ).

Conclusions This study shows that in patients with STEMI treated by primary angioplasty prolonged ischaemic time is associated with impaired myocardial perfusion, larger infarct size, and higher 1-year mortality. Therefore, all efforts should be made to shorten ischaemic time as much as possible to achieve better myocardial perfusion and myocardial salvage in primary angioplasty for STEMI.

Key Words: Primary angioplasty • Myocardial infarction • Ischaemic time • Myocardial perfusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Time is muscle in primary PCI: the strength of the evidence grows
C.Michael Gibson, James A. de Lemos, Elliott M. Antman, and from the TIMI Study Group
EHJ 2004 25: 1001-1002. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
BMJHome page
S. S Rathore, J. P Curtis, J. Chen, Y. Wang, B. K Nallamothu, A. J Epstein, H. M Krumholz, and for the National Cardiovascular Data Registry
Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study
BMJ, May 19, 2009; 338(may19_1): b1807 - b1807.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G De Luca, C M Gibson, F Bellandi, S Murphy, M Maioli, M Noc, U Zeymer, D Dudek, H-R Arntz, S Zorman, et al.
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
Heart, December 1, 2008; 94(12): 1548 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G. De Luca
Adjunctive antithrombotic therapy during primary percutaneous coronary intervention
Eur. Heart J. Suppl., December 1, 2008; 10(suppl_J): J2 - J14.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. E. Buller, Y. Fu, K. W. Mahaffey, T. G. Todaro, P. Adams, C. M. Westerhout, H. D. White, A. W.J. van 't Hof, F. J. Van de Werf, G. S. Wagner, et al.
ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial
Circulation, September 23, 2008; 118(13): 1335 - 1346.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Tricoci, Y. Lokhnygina, L. G. Berdan, S. R. Steinhubl, D. C. Gulba, H. D. White, N. S. Kleiman, P. E. Aylward, A. Langer, R. M. Califf, et al.
Time to Coronary Angiography and Outcomes Among Patients With High-Risk Non ST-Segment Elevation Acute Coronary Syndromes: Results From the SYNERGY Trial
Circulation, December 4, 2007; 116(23): 2669 - 2677.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. E. Boden, K. Eagle, and C. B. Granger
Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options
J. Am. Coll. Cardiol., September 4, 2007; 50(10): 917 - 929.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Napodano, A. Ramondo, and S. Iliceto
Adjunctive Thrombectomy in Acute Myocardial Infarction: For Some but Not for All
J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1586 - 1586.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
P. A Ratner, R. Tzianetas, A. W Tu, J. L Johnson, M. Mackay, C. E Buller, M. Rowlands, and B. Reime
Myocardial infarction symptom recognition by the lay public: the role of gender and ethnicity.
J Epidemiol Community Health, July 1, 2006; 60(7): 606 - 615.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L De Luca, G Sardella, C J Davidson, G De Persio, M Beraldi, T Tommasone, M Mancone, B L Nguyen, L Agati, M Gheorghiade, et al.
Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction
Heart, July 1, 2006; 92(7): 951 - 957.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G De Luca, H Suryapranata, and M Chiariello
Aspiration thrombectomy and primary percutaneous coronary intervention
Heart, July 1, 2006; 92(7): 867 - 869.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 5: Acute Coronary Syndromes
Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben
Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury
Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Tarantini, L. Cacciavillani, F. Corbetti, A. Ramondo, M. P. Marra, E. Bacchiega, M. Napodano, C. Bilato, R. Razzolini, and S. Iliceto
Duration of Ischemia Is a Major Determinant of Transmurality and Severe Microvascular Obstruction After Primary Angioplasty: A Study Performed With Contrast-Enhanced Magnetic Resonance
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1229 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. W.J. van 't Hof, H. van de Wetering, N. Ernst, F. Hollak, F. de Pooter, H. Suryapranata, J. C.A. Hoorntje, J.-H. E. Dambrink, M. Gosselink, F. Zijlstra, et al.
A quantitative analysis of the benefits of pre-hospital infarct angioplasty triage on outcome in patients undergoing primary angioplasty for acute myocardial infarction
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_K): K36 - K40.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H S Gurm and E J Topol
The ECG in acute coronary syndromes: new tricks from an old dog
Heart, July 1, 2005; 91(7): 851 - 853.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. W. O'Neill, S. R. Dixon, and C. L. Grines
The year in interventional cardiology
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1117 - 1134.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al.
Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Eur. Heart J., April 2, 2005; 26(8): 804 - 847.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G. De Luca, A. W.J. van 't Hof, J. P. Ottervanger, J. C.A. Hoorntje, A.T. M. Gosselink, J.-H. E. Dambrink, M.-J. de Boer, and H. Suryapranata
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
Eur. Heart J., April 1, 2005; 26(7): 662 - 666.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Agewall
How should we evaluate an open artery in STEMI patients?
Eur. Heart J., April 1, 2005; 26(7): 634 - 636.
[Full Text] [PDF]


Home page
JWatch Emergency Med.Home page
Faster Angioplasty for STEMI Improves Outcomes
Journal Watch Emergency Medicine, October 13, 2004; 2004(1013): 1 - 1.
[Full Text]


Home page
Eur Heart JHome page
D. Perera, G. Kanaganayagam, and M. Marber
Stem cells in unstable angina: the dynamic duo
Eur. Heart J., June 2, 2004; 25(12): 999 - 1000.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C.M. Gibson, J. A. de Lemos, E. M. Antman, and from the TIMI Study Group
Time is muscle in primary PCI: the strength of the evidence grows
Eur. Heart J., June 2, 2004; 25(12): 1001 - 1002.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.